The Department of Clinical Haematology provides services for patients with benign and malignant haematological disorders. Therapeutic and diagnostic services are provided to approximately 200 new patients diagnosed with haematological cancers annually.
This includes the care of patients with acute and chronic leukaemias, lymphoma, myeloma and myelodysplastic syndromes. Services are provided to inpatients, outpatients and through our dedicated Haematology Day Ward. The department is staffed with specialised medical, nursing and allied health professional staff. Services include intensive chemotherapy for patients with malignancy including acute leukaemia and stem cell transplant patients. Consultative services are provided to the medical and surgical patients in the hospital on a 24-hour basis. Outpatient and Rapid Access Clinics and a Nurse-led Lymphoma Clinic are provided. A specialised thrombophilia clinic is also provided, and the Department is responsible for the provision of Anticoagulation Clinics for the hospital and catchment area.
Consultative, on-call and laboratory Services are provided to Naas Hospital. Research activities are focused on participation in Haematological Oncology Clinical Trials and on the investigation and treatment of patients with Myelodysplastic Syndromes. The Department is recognised internationally as a Centre of Excellence for the Diagnosis and Management of Myelodysplastic Syndromes.
The Haematology Department at Tallaght is recognised by the International Myelodysplastic Syndromes Foundation as a Centre of Excellence for the diagnosis and treatment of Myelodysplastic Syndromes (MDS). Tallaght is the only such recognised centre in Ireland.
Much of our research is focussed on MDS and similar marrow failure syndromes, and we act in an advisory role for Irish Physicians and Irish patients with MDS, who often come to see us for a second opinion.
